Dr. Rodrigo Bagur, MD
Claim this profileLondon Health Sciences Centre - University Campus
Studies Stroke
Studies Thrombus
2 reported clinical trials
3 drugs studied
Affiliated Hospitals
Clinical Trials Rodrigo Bagur, MD is currently running
TAVR
for Aortic Stenosis
Obtain safety and effectiveness data to support indication expansion for the Medtronic TAVR System to include patients with moderate, AS.
Recruiting1 award N/A3 criteria
Extended CTA
for Ischemic Stroke Detection
Embolic strokes of undetermined source (ESUS) represent a subset of cryptogenic strokes that are suspected to have an occult embolic source. The risk of stroke recurrence in patients with ESUS varies between 1.9%/year and 19.0%/year depending on the prevalence of vascular risk factors. Part of the elevated recurrence rate is due to the inability to identify high-risk treatable causes such as cardiac thrombi as those found in the left atrial appendage (LAA), left atrium (LA), left ventricle (LV), valves, or aortic arch. The most frequently used diagnostic method in clinical practice to detect cardioaortic thrombi is transesophageal echocardiography (TEE). However, the relatively low availability, higher cost, and invasive nature of TEE limit its large-scale usability. In most stroke centers, patients presenting with an acute ischemic stroke or TIA undergo a tomography (CT) angiography (CTA) of the neck and intracranial vessels. This standard of care CTA (sCTA) classically includes the aortic arch, the higher portion of the ascending/descending aorta, and the rostral portion of the cardiac chambers, but does not involve the LAA, LV, or cardiac valves. A recent study performed among 300 patients with an acute ischemic stroke showed an overall LAA thrombus detection of 6.6% and 15% in patients with AF by extending the CTA 6 cm below the carina. This is an extraordinarily high prevalence of LAA compared to 0.5% to 4.8% of intracardiac thrombi identified on TEE in most previous studies. The major limitation of previous CTA and TEE studies is their observational design, so the differing prevalence of LAA thrombi could be explained by dissimilar population characteristics or selection bias. Based on the methodological limitation of prior studies and the promising role of extended CTAs (eCTA), a randomized controlled trial comparing eCTA + standard of care stroke workup vs. sCTA + standard of care stroke workup is needed.
Recruiting1 award N/A
More about Rodrigo Bagur, MD
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Rodrigo Bagur, MD has experience with
- Extended CTA
- Evolut FX TAVR System
- Medtronic Evolut PRO+ TAVR System
Breakdown of trials Rodrigo Bagur, MD has run
Mini-stroke
Intracardiac Thrombus
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Rodrigo Bagur, MD specialize in?
Rodrigo Bagur, MD focuses on Stroke and Thrombus. In particular, much of their work with Stroke has involved treating patients, or patients who are undergoing treatment.
Is Rodrigo Bagur, MD currently recruiting for clinical trials?
Yes, Rodrigo Bagur, MD is currently recruiting for 2 clinical trials in London Ontario. If you're interested in participating, you should apply.
Are there any treatments that Rodrigo Bagur, MD has studied deeply?
Yes, Rodrigo Bagur, MD has studied treatments such as extended CTA, Evolut FX TAVR System, Medtronic Evolut PRO+ TAVR System.
What is the best way to schedule an appointment with Rodrigo Bagur, MD?
Apply for one of the trials that Rodrigo Bagur, MD is conducting.
What is the office address of Rodrigo Bagur, MD?
The office of Rodrigo Bagur, MD is located at: London Health Sciences Centre - University Campus, London, Ontario N6A 5A5 Canada. This is the address for their practice at the London Health Sciences Centre - University Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.